Effect of Moisturizing Creams on Skin Barrier Function

Phase 4

• Conditions: Atopic Eczema
• Interventions: Drug: urea/lactic acid; Drug: Placebo

• Registration Number: NCT00771121
• Lead Sponsor: ACO Hud Nordic AB

Brief Summary

This study is a randomized, double-blind, placebo-controlled bilateral study on the effect of moisturizing creams on skin barrier function. The hypothesis is that a new active emulsion has a better influence on skin barrier function comapred to its placebo.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-10
• Study First Submitted: 2008-10-10
• Study First Submitted QC: 2008-10-10
• Last Update Submitted: 2008-10-10
• Study First Posted: 2008-10-13
• Last Update Posted: 2008-10-13

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Dry skin barrier disorders such as atopic dermatitis or Malassezia eradicated head and neck dermatitis.
• Rough or clinically normal skin on the volar aspect of the forearm.
• Either gender
• Age between 18 and 65 years
• Written Informed Consent

Read More

Exclusion Criteria

• Possible allergy to ingredients in the study medications.
• Use of any concomitant medication that may interfere with the study related activities or assessment of efficacy.
• Any patient related factor suggesting potential poor compliance with study procedures (e.g. psychiatric disorders, history of alcohol or substance abuse).
• Any serious medical condition which, in the opinion of the investigator, may interfere with the evaluation of the results.
• Pregnancy or breast feeding, or patients who plan to become pregnant during the course of the study.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
new emulsion	urea/lactic acid	-
new emulsion placebo	Placebo	-

Trial Locations

Locations (1)

Sophiahemmet; 🇸🇪 Stockholm, Sweden